3

rezultat(e)

Cuvânt (cuvinte)
Tipul publicației
Domeniul tematic
Autor
Cuvânt-cheie
Data

Road safety in the EU

26-02-2019

Between 1991 and 2017, and especially after 2000, the EU witnessed substantial improvements in terms of road safety, whether measured in terms of fatalities, accidents or injuries. Over a shorter period, between 2001 and 2010, the number of deaths on EU roads decreased by 43 %, and by around another 20 % since 2010. The most recent figures, however, show that progress in reducing the fatality rate is stagnating, and that specific road users or demographic groups are not witnessing the same improvements ...

Between 1991 and 2017, and especially after 2000, the EU witnessed substantial improvements in terms of road safety, whether measured in terms of fatalities, accidents or injuries. Over a shorter period, between 2001 and 2010, the number of deaths on EU roads decreased by 43 %, and by around another 20 % since 2010. The most recent figures, however, show that progress in reducing the fatality rate is stagnating, and that specific road users or demographic groups are not witnessing the same improvements as the rest of the population. Road safety is a shared competence, implying that many measures are primarily dealt with by Member States. However, the EU, in line with Article 91(c) TFEU, has significantly developed the acquis in this area, with the Commission adopting several policy frameworks on road safety. In 2003, the EU set itself a target in terms of reducing road fatalities, and regularly monitors progress towards this goal. In June 2017, the Council endorsed the Valletta Declaration, which reasserted commitments and targets in the area of road safety. In May 2018, within the context of the third and last 'mobility package', the Commission presented a common framework for road safety for the 2021-2030 period, recalling the EU’s long-term goal of moving as close as possible to zero fatalities in road transport by 2050 ('Vision Zero'). The European Parliament has adopted numerous resolutions regarding or covering road safety, calling notably for more detailed and measurable targets, more account taken of vulnerable users as well as of the safety challenges emerging from the development of connected and automated mobility. This is an updated edition of a Briefing published in November 2016: PE 593.542.

Clinical Trials in Developing Countries : How to Protect People Against Unethical Practices ?

27-03-2009

Executive summary European legislation regulating the marketing authorisation of medical products states that results from clinical trials that do not meet the ethical requirements of Good Clinical Practice, cannot legally be used by an applicant to justify its application, irrespective of whether the trial was done inside or outside the EU. However, earlier studies indicate that this legislation is not always properly observed: these studies identified trials with an unethical design that were part ...

Executive summary European legislation regulating the marketing authorisation of medical products states that results from clinical trials that do not meet the ethical requirements of Good Clinical Practice, cannot legally be used by an applicant to justify its application, irrespective of whether the trial was done inside or outside the EU. However, earlier studies indicate that this legislation is not always properly observed: these studies identified trials with an unethical design that were part of approved EU marketing applications. Clinical trials that are no longer accepted by Western European ethics committees are approved by the local ethics committees in countries like India, China, Argentina and Russia. Once officially approved by an ethics committee, there are no obstacles to including the trial in the technical dossier of a marketing application. In particular the ethical principles which are of utmost importance for developing countries, as reflected in the Declaration of Helsinki, are ignored by companies and regulatory authorities. The main objective of this paper is to provide the European Parliament with concrete recommendations, both at legislative and enforcement level, aimed to guarantee that trials conducted in third countries are done so in conformity with EU and international ethical standards. [...]

Autor extern

Irene Schipper (SOMO - Center for Research on Multinational Companies, Amsterdam, Holland)

Impact of Selected Topics related to the Proposed Directive on Pyrotechnic Articles

01-08-2006

Autor extern

Andrea Renda, Lorna Schrefler, Centre for European Policy Studies (CEPS).

Evenimente viitoare

21-09-2021
EPRS online Book Talk with David Harley: Inside the room - Shaping Europe, 1992-2010
Alt eveniment -
EPRS
21-09-2021
Putting the 'e' in e-Health
Atelier -
STOA
27-09-2021
Turning the tide on cancer: the national parliaments' view on Europe's Cancer Plan
Alt eveniment -
BECA

Parteneri